id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S17127 R71771 |
Delteil - Beta-blockers, 2024 | Very preterm birth (28-32 GW) | at least 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Indications Antihypertensive: Only chronic indication (hypertension or cardiac) | 1.94 [1.02;3.68] | 10/421 617/142,505 | 627 | 421 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17151 R71928 |
Al Khalaf - Beta-blockers (Controls unexposed, disease free), 2022 | Very preterm birth (less than 32 weeks) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, disease free excluded | Adjustment: No Indications Antihypertensive: Only chronic hypertension indication |
4.15 [3.29;5.24] C excluded (control group) |
74/1,827 17,507/1,739,944 | 17,581 | 1,827 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17148 R71905 |
Al Khalaf - Beta-blockers (Controls unexposed, sick), 2022 | Very preterm birth (less than 32 weeks) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: No Indications Antihypertensive: Only chronic hypertension indication | 1.58 [1.21;2.07] C | 74/1,827 203/7,809 | 277 | 1,827 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13392 R54161 |
Ray - Beta-blockers, 2001 | Preterm birth before 32 weeks gestation | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: Yes Indications Antihypertensive: Only chronic hypertension indication | 4.00 [1.30;12.40] | 15/144 5/247 | 20 | 144 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 1.81 [1.27;2.59] | 924 | 2,392 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 17151